Cargando…
Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis
BACKGROUND: Getting access to authentic human drug metabolites is an important issue during the drug discovery and development process. Employing recombinant microorganisms as whole-cell biocatalysts constitutes an elegant alternative to organic synthesis to produce these compounds. The present work...
Autores principales: | Geier, Martina, Bachler, Thorsten, Hanlon, Steven P, Eggimann, Fabian K, Kittelmann, Matthias, Weber, Hansjörg, Lütz, Stephan, Wirz, Beat, Winkler, Margit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464233/ https://www.ncbi.nlm.nih.gov/pubmed/26062974 http://dx.doi.org/10.1186/s12934-015-0262-0 |
Ejemplares similares
-
Drug metabolite synthesis by immobilized human FMO3 and whole cell catalysts
por: Gao, Chongliang, et al.
Publicado: (2019) -
Expression of Concern to: Drug metabolite synthesis by immobilized human FMO3 and whole cell catalysts
por: Gao, Chongliang, et al.
Publicado: (2020) -
Production of drug metabolites by human FMO3 in Escherichia coli
por: Catucci, Gianluca, et al.
Publicado: (2020) -
Revisiting the optical properties of the FMO protein
por: Milder, Maaike T. W., et al.
Publicado: (2010) -
Human Enzymes for Organic Synthesis
por: Winkler, Margit, et al.
Publicado: (2018)